We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

2 similar Royalty Agreement contracts by Titan Pharmaceuticals Inc

EX-10.3 6 dex103.htm ROYALTY AGREEMENT ROYALTY AGREEMENT
Royalty Agreement • May 5th, 2020 • New York

This ROYALTY AGREEMENT (this “Agreement”), dated March 15, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS”), Deerfield TTNP Corporation, a Delaware corporation (“DTTNP” and together with Design Fund II and DSS, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).

Standard Contracts

ROYALTY AGREEMENT
Royalty Agreement • March 18th, 2011 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

This ROYALTY AGREEMENT (this “Agreement”), dated March 15, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS”), Deerfield TTNP Corporation, a Delaware corporation (“DTTNP” and together with Design Fund II and DSS, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).